-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Enanta Pharma, Maintains $21 Price Target

Benzinga·02/11/2025 15:43:22
Listen to the news
JMP Securities analyst Roy Buchanan reiterates Enanta Pharma (NASDAQ:ENTA) with a Market Outperform and maintains $21 price target.